Optipharm.CO.,LTD (KOSDAQ:153710)
South Korea
· Delayed Price · Currency is KRW 5,210.00
+60.00 (1.17%)
At close: Apr 28, 2026
Optipharm.CO.,LTD Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 22,345 | 19,636 | 17,373 | 16,008 | 14,258 | Upgrade
|
| Other Revenue | -0 | -0 | - | - | -0 | Upgrade
|
| Revenue | 22,345 | 19,636 | 17,373 | 16,008 | 14,258 | Upgrade
|
| Revenue Growth (YoY) | 13.79% | 13.03% | 8.52% | 12.27% | 9.29% | Upgrade
|
| Cost of Revenue | 16,757 | 14,741 | 13,177 | 12,293 | 10,522 | Upgrade
|
| Gross Profit | 5,587 | 4,896 | 4,195 | 3,715 | 3,736 | Upgrade
|
| Selling, General & Admin | 4,447 | 3,946 | 3,301 | 2,546 | 2,729 | Upgrade
|
| Research & Development | 2,821 | 2,802 | 2,946 | 2,632 | 5,022 | Upgrade
|
| Amortization of Goodwill & Intangibles | 22.86 | 22.83 | 22.56 | 22.05 | 25.3 | Upgrade
|
| Other Operating Expenses | 268.99 | 187.32 | 184.01 | 363.43 | 118.5 | Upgrade
|
| Operating Expenses | 8,001 | 7,348 | 6,826 | 5,904 | 8,241 | Upgrade
|
| Operating Income | -2,414 | -2,452 | -2,631 | -2,188 | -4,505 | Upgrade
|
| Interest Expense | -504.07 | -544.33 | -477.34 | -353.51 | -173.78 | Upgrade
|
| Interest & Investment Income | 372.71 | 598.82 | 665.39 | 464.38 | 234.2 | Upgrade
|
| Earnings From Equity Investments | - | - | -1.49 | -0.35 | -0.29 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.67 | 0.02 | 0.12 | -1.38 | -3.48 | Upgrade
|
| Other Non Operating Income (Expenses) | 64.1 | 39.74 | 6.52 | 31.2 | 1,370 | Upgrade
|
| EBT Excluding Unusual Items | -2,483 | -2,358 | -2,438 | -2,048 | -3,078 | Upgrade
|
| Gain (Loss) on Sale of Assets | -16.24 | 0.97 | 1.06 | 3.31 | -1.76 | Upgrade
|
| Pretax Income | -2,499 | -2,357 | -2,437 | -2,045 | -3,080 | Upgrade
|
| Net Income | -2,499 | -2,357 | -2,437 | -2,045 | -3,080 | Upgrade
|
| Net Income to Common | -2,499 | -2,357 | -2,437 | -2,045 | -3,080 | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | 0.44% | -0.22% | 0.45% | 0.54% | 0.66% | Upgrade
|
| EPS (Basic) | -170.00 | -161.00 | -166.10 | -140.00 | -212.00 | Upgrade
|
| EPS (Diluted) | -170.00 | -161.00 | -166.10 | -140.00 | -212.00 | Upgrade
|
| Free Cash Flow | -4,062 | -2,273 | -3,395 | -6,968 | -2,695 | Upgrade
|
| Free Cash Flow Per Share | -276.27 | -155.29 | -231.40 | -477.10 | -185.50 | Upgrade
|
| Gross Margin | 25.01% | 24.93% | 24.15% | 23.21% | 26.20% | Upgrade
|
| Operating Margin | -10.80% | -12.49% | -15.14% | -13.67% | -31.59% | Upgrade
|
| Profit Margin | -11.19% | -12.00% | -14.03% | -12.77% | -21.60% | Upgrade
|
| Free Cash Flow Margin | -18.18% | -11.58% | -19.54% | -43.53% | -18.90% | Upgrade
|
| EBITDA | -739.92 | -837.6 | -1,198 | -1,068 | -3,429 | Upgrade
|
| EBITDA Margin | -3.31% | -4.27% | -6.89% | -6.67% | -24.05% | Upgrade
|
| D&A For EBITDA | 1,674 | 1,614 | 1,433 | 1,120 | 1,076 | Upgrade
|
| EBIT | -2,414 | -2,452 | -2,631 | -2,188 | -4,505 | Upgrade
|
| EBIT Margin | -10.80% | -12.49% | -15.14% | -13.67% | -31.59% | Upgrade
|
| Advertising Expenses | 27.81 | 31.26 | 28.73 | 92.55 | 22.55 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.